{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:10:16Z","timestamp":1772647816801,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T00:00:00Z","timestamp":1643500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T00:00:00Z","timestamp":1643500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"China National Cancer Center Climbing Fund","award":["#NCC201822872"],"award-info":[{"award-number":["#NCC201822872"]}]},{"name":"Open research fund project of Chongqing University Cancer Hospital"},{"name":"General project of Chongqing Natural Science Foundation","award":["cstc2021jcyj-msxmX0447"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0447"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Renal cell carcinoma (RCC) is a heterogeneous group of kidney cancers. Renal capsule invasion is an essential factor for RCC staging. To develop radiomics models from CT images for the preoperative prediction of capsule invasion in RCC patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study included patients with RCC admitted to the Chongqing University Cancer Hospital (01\/2011\u201305\/2019). We built a radiomics model to distinguish patients grouped as capsule invasion versus non-capsule invasion, using preoperative CT scans. We evaluated effects of three imaging phases, i.e., unenhanced phases (UP), corticomedullary phases (CMP), and nephrographic phases (NP). Five different machine learning classifiers were compared. The effects of tumor and tumor margins are also compared. Five-fold cross-validation and the area under the receiver operating characteristic curve (AUC) are used to evaluate model performance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study included 126 RCC patients, including 46 (36.5%) with capsule invasion. CMP exhibited the highest AUC (AUC\u2009=\u20090.81) compared to UP and NP, when using the forward neural network (FNN) classifier. The AUCs using features extracted from the tumor region were generally higher than those of the marginal regions in the CMP (0.81 vs. 0.73) and NP phase (AUC\u2009=\u20090.77 vs. 0.76). For UP, the best result was obtained from the marginal region (AUC\u2009=\u20090.80). The robustness analysis on the UP, CMP, and NP achieved the AUC of 0.76, 0.79, and 0.77, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Radiomics features in renal CT imaging are associated with the renal capsule invasion in RCC patients. Further evaluation of the models is warranted.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12880-022-00741-5","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T14:02:10Z","timestamp":1643551330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A CT-based radiomics model for predicting renal capsule invasion in renal cell carcinoma"],"prefix":"10.1186","volume":"22","author":[{"given":"Lu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dooman","family":"Arefan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanli","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,30]]},"reference":[{"key":"741_CR1","volume-title":"WHO classification of tumours of the urinary system and male genital organs","author":"H Moch","year":"2016","unstructured":"Moch H, Humphrey PA, Ulbright TM, Reuter V. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer; 2016."},{"key":"741_CR2","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Kidney Cancer. Version 1.2021. Fort Washington: National Comprehensive Cancer Network; 2020."},{"key":"741_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","volume":"387","author":"U Capitanio","year":"2016","unstructured":"Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387:894\u2013906.","journal-title":"Lancet"},{"key":"741_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"741_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"741_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12094-017-1765-4","volume":"20","author":"E Gallardo","year":"2018","unstructured":"Gallardo E, Mendez-Vidal MJ, Perez-Gracia JL, Sepulveda-Sanchez JM, Campayo M, Chirivella-Gonzalez I, et al. SEOM clinical guideline for treatment of kidney cancer (2017). Clin Transl Oncol. 2018;20:47\u201356.","journal-title":"Clin Transl Oncol"},{"key":"741_CR7","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.urolonc.2011.12.019","volume":"31","author":"T Song","year":"2013","unstructured":"Song T, Yin Y, Liao B, Zheng S, Wei Q. Capsular invasion in renal cell carcinoma: a meta-analysis. Urol Oncol. 2013;31:1321\u20136.","journal-title":"Urol Oncol"},{"key":"741_CR8","first-page":"920","volume":"19","author":"X Qin","year":"2009","unstructured":"Qin X, Dingwei Y, Yao XD, Zhang S, Zhu Y, Zhang HL, et al. Role of renal capsular involvement status in renal cell carcinoma. China Oncol. 2009;19:920\u20133.","journal-title":"China Oncol"},{"key":"741_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1464-410X.2006.06729.x","volume":"99","author":"T Klatte","year":"2007","unstructured":"Klatte T, Chung J, Leppert JT, Lam JS, Pantuck AJ, Figlin RA, et al. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma. BJU Int. 2007;99:821\u20134.","journal-title":"BJU Int"},{"key":"741_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.pan.2018.04.016","volume":"18","author":"S Choosakul","year":"2018","unstructured":"Choosakul S, Harinwan K, Chirapongsathorn S, Opuchar K, Sanpajit T, Piyanirun W, et al. Comparison of normal saline versus Lactated Ringer\u2019s solution for fluid resuscitation in patients with mild acute pancreatitis. A randomized controlled trial. Pancreatology. 2018;18:507\u201312.","journal-title":"Pancreatology"},{"key":"741_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.urolonc.2008.07.008","volume":"28","author":"M May","year":"2010","unstructured":"May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, et al. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view. Urol Oncol. 2010;28:274\u20139.","journal-title":"Urol Oncol"},{"key":"741_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.urology.2005.10.042","volume":"67","author":"IG Jeong","year":"2006","unstructured":"Jeong IG, Jeong CW, Hong SK, Kwak C, Lee E, Lee SE. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma. Urology. 2006;67:709\u201312.","journal-title":"Urology"},{"key":"741_CR13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/01.ju.0000173631.01329.1f","volume":"174","author":"SM Bonsib","year":"2005","unstructured":"Bonsib SM. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. J Urol. 2005;174:1199\u2013202 (discussion 202).","journal-title":"J Urol."},{"key":"741_CR14","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.crad.2017.06.003","volume":"72","author":"H Zhang","year":"2017","unstructured":"Zhang H, Wu Y, Xue W, Zuo P, Oesingmann N, Gan Q, et al. Arterial spin labelling MRI for detecting pseudocapsule defects and predicting renal capsule invasion in renal cell carcinoma. Clin Radiol. 2017;72:936\u201343.","journal-title":"Clin Radiol"},{"key":"741_CR15","doi-asserted-by":"publisher","first-page":"e13075","DOI":"10.1097\/MD.0000000000013075","volume":"97","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Tian H, Zhang S, Zhang Q, Wu X. Multislice spiral computed tomography signs of invasion of the renal capsule by renal cell carcinoma. Medicine (Baltimore). 2018;97:e13075.","journal-title":"Medicine (Baltimore)"},{"key":"741_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.juro.2016.07.086","volume":"197","author":"C Snarskis","year":"2017","unstructured":"Snarskis C, Calaway AC, Wang L, Gondim D, Hughes I, Idrees MT, et al. Standardized reporting of microscopic renal tumor margins: introduction of the renal tumor capsule invasion scoring system. J Urol. 2017;197:23\u201330.","journal-title":"J Urol"},{"key":"741_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","volume":"11","author":"JE van Timmeren","year":"2020","unstructured":"van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B. Radiomics in medical imaging-\"how-to\" guide and critical reflection. Insights Imaging. 2020;11:91.","journal-title":"Insights Imaging"},{"key":"741_CR18","doi-asserted-by":"publisher","first-page":"108991","DOI":"10.1016\/j.ejrad.2020.108991","volume":"127","author":"J Song","year":"2020","unstructured":"Song J, Yin Y, Wang H, Chang Z, Liu Z, Cui L. A review of original articles published in the emerging field of radiomics. Eur J Radiol. 2020;127:108991.","journal-title":"Eur J Radiol"},{"key":"741_CR19","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00261-019-01929-0","volume":"44","author":"H Coy","year":"2019","unstructured":"Coy H, Hsieh K, Wu W, Nagarajan MB, Young JR, Douek ML, et al. Deep learning and radiomics: the utility of Google TensorFlow Inception in classifying clear cell renal cell carcinoma and oncocytoma on multiphasic CT. Abdom Radiol (NY). 2019;44:2009\u201320.","journal-title":"Abdom Radiol (NY)"},{"key":"741_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.tranon.2018.10.012","volume":"12","author":"L Zhou","year":"2019","unstructured":"Zhou L, Zhang Z, Chen YC, Zhao ZY, Yin XD, Jiang HB. A Deep learning-based radiomics model for differentiating benign and malignant renal tumors. Transl Oncol. 2019;12:292\u2013300.","journal-title":"Transl Oncol"},{"key":"741_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejrad.2018.04.013","volume":"103","author":"J Ding","year":"2018","unstructured":"Ding J, Xing Z, Jiang Z, Chen J, Pan L, Qiu J, et al. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma. Eur J Radiol. 2018;103:51\u20136.","journal-title":"Eur J Radiol"},{"key":"741_CR22","doi-asserted-by":"publisher","first-page":"108738","DOI":"10.1016\/j.ejrad.2019.108738","volume":"121","author":"J Shu","year":"2019","unstructured":"Shu J, Wen D, Xi Y, Xia Y, Cai Z, Xu W, et al. Clear cell renal cell carcinoma: Machine learning-based computed tomography radiomics analysis for the prediction of WHO\/ISUP grade. Eur J Radiol. 2019;121:108738.","journal-title":"Eur J Radiol"},{"key":"741_CR23","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.crad.2018.04.009","volume":"73","author":"Q Yin","year":"2018","unstructured":"Yin Q, Hung SC, Rathmell WK, Shen L, Wang L, Lin W, et al. Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma. Clin Radiol. 2018;73:782\u201391.","journal-title":"Clin Radiol"},{"key":"741_CR24","volume-title":"WHO classification of tumours of the urinary system and male genital organs","author":"JN Eble","year":"2004","unstructured":"Eble JN, Sauter G, Epstein JI, Sesterhenn IA. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer; 2004."},{"key":"741_CR25","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77:e104\u20137.","journal-title":"Cancer Res"},{"key":"741_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1467-9868.2011.00771.x","volume":"73","author":"R Tibshirani","year":"2011","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso: a retrospective. J R Stat Soc B. 2011;73:273\u201382.","journal-title":"J R Stat Soc B"},{"key":"741_CR27","doi-asserted-by":"publisher","first-page":"19726","DOI":"10.1038\/s41598-020-74419-9","volume":"10","author":"L Pei","year":"2020","unstructured":"Pei L, Vidyaratne L, Rahman MM, Iftekharuddin KM. Context aware deep learning for brain tumor segmentation, subtype classification, and survival prediction using radiology images. Sci Rep. 2020;10:19726.","journal-title":"Sci Rep"},{"key":"741_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2020.00053","volume":"10","author":"Q Sun","year":"2020","unstructured":"Sun Q, Lin X, Zhao Y, Li L, Yan K, Liang D, et al. Deep learning vs. radiomics for predicting axillary lymph node metastasis of breast cancer using ultrasound images: don\u2019t forget the peritumoral region. Front Oncol. 2020;10:53.","journal-title":"Front Oncol"},{"key":"741_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.18383\/j.tom.2019.00021","volume":"6","author":"MD Holbrook","year":"2020","unstructured":"Holbrook MD, Blocker SJ, Mowery YM, Badea A, Qi Y, Xu ES, et al. MRI-based deep learning segmentation and radiomics of sarcoma in mice. Tomography. 2020;6:23\u201333.","journal-title":"Tomography"},{"key":"741_CR30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3322\/caac.21552","volume":"69","author":"WL Bi","year":"2019","unstructured":"Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. 2019;69:127\u201357.","journal-title":"CA Cancer J Clin"},{"key":"741_CR31","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3389\/fonc.2020.00680","volume":"10","author":"SH Zhen","year":"2020","unstructured":"Zhen SH, Cheng M, Tao YB, Wang YF, Juengpanich S, Jiang ZY, et al. Deep learning for accurate diagnosis of liver tumor based on magnetic resonance imaging and clinical data. Front Oncol. 2020;10:680.","journal-title":"Front Oncol"},{"key":"741_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2214\/AJR.19.22074","volume":"214","author":"T Tanaka","year":"2020","unstructured":"Tanaka T, Huang Y, Marukawa Y, Tsuboi Y, Masaoka Y, Kojima K, et al. Differentiation of small (<\/= 4 cm) renal masses on multiphase contrast-enhanced CT by deep learning. AJR Am J Roentgenol. 2020;214:605\u201312.","journal-title":"AJR Am J Roentgenol"},{"key":"741_CR33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1148\/radiol.2017170706","volume":"286","author":"K Yasaka","year":"2018","unstructured":"Yasaka K, Akai H, Abe O, Kiryu S. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast-enhanced CT: a preliminary study. Radiology. 2018;286:887\u201396.","journal-title":"Radiology"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-022-00741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-022-00741-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-022-00741-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T14:32:50Z","timestamp":1700145170000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-022-00741-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,30]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1186\/s12880-022-00741-5","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,30]]},"assertion":[{"value":"9 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was a retrospective study and was approved by the ethics committee of the Chongqing University Cancer Hospital (CZLS2021068-A). The requirement for informed consent was waived by the ethics committee of the Chongqing University Cancer Hospital. Authors confirm that all methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}